BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38458548)

  • 1. Association between lymph node ratio and survival outcomes in patients with oral squamous cell carcinoma.
    Haraguchi K; Habu M; Takahashi O; Tominaga K; Yoshioka I; Sasaguri M
    J Stomatol Oral Maxillofac Surg; 2024 Jun; 125(3S):101816. PubMed ID: 38458548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Lymph Node Ratio a Prognostic Factor for Patients With Oral Squamous Cell Carcinoma?
    Yamagata K; Fukuzawa S; Kanno N; Uchida F; Yanagawa T; Bukawa H
    J Oral Maxillofac Surg; 2019 Jul; 77(7):1510-1519. PubMed ID: 30822404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of lymph-node ratio as a prognostic factor for patients with oral squamous cell carcinoma.
    Tomo S; Araújo WAF; de Castro TF; Neto SC; Collado FU; Biasoli ÉR; Bernabé DG; Miyahara GI
    J Stomatol Oral Maxillofac Surg; 2022 Nov; 123(6):e814-e821. PubMed ID: 35998818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymph node ratio as prognosticator in floor of mouth squamous cell carcinoma patients.
    Zirk M; Safi AF; Buller J; Nickenig HJ; Dreiseidler T; Zinser M; Drebber U; Zöller JE; Kreppel M
    J Craniomaxillofac Surg; 2018 Feb; 46(2):195-200. PubMed ID: 29249633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymph node ratio as an independent prognostic factor in oral squamous cell carcinoma.
    Ebrahimi A; Clark JR; Zhang WJ; Elliott MS; Gao K; Milross CG; Shannon KF
    Head Neck; 2011 Sep; 33(9):1245-51. PubMed ID: 20967874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of lymph node ratio in patients with squamous cell carcinoma of the floor of the mouth.
    Liu XC; Ma SR; Shi S; Zhao YF; Jia J
    Int J Oral Maxillofac Surg; 2022 Mar; 51(3):307-313. PubMed ID: 34281747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can metastatic lymph node ratio (LNR) predict survival in oral cavity cancer patients?
    Sayed SI; Sharma S; Rane P; Vaishampayan S; Talole S; Chaturvedi P; Chaukar D; Deshmukh A; Agarwal JP; D'cruz AK
    J Surg Oncol; 2013 Sep; 108(4):256-63. PubMed ID: 23893514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node ratio as a predictor for outcome in oral squamous cell carcinoma: a multicenter population-based cohort study.
    Spoerl S; Gerken M; Mamilos A; Fischer R; Wolf S; Nieberle F; Klingelhöffer C; Meier JK; Spoerl S; Ettl T; Reichert TE; Spanier G
    Clin Oral Investig; 2021 Apr; 25(4):1705-1713. PubMed ID: 32754787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of lymph node ratio on survival and recurrence outcomes in oral squamous cell carcinoma.
    Mamic M; Lucijanic M; Lorencin M; Suton P; Luksic I
    Int J Oral Maxillofac Surg; 2022 Oct; 51(10):1257-1263. PubMed ID: 35101318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of lymph node ratio for patients with mandibular infiltration of oral squamous cell carcinoma.
    Safi AF; Kauke M; Grandoch A; Nickenig HJ; Zöller J; Kreppel M
    J Craniomaxillofac Surg; 2018 Jun; 46(6):1007-1012. PubMed ID: 29709331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph node ratio as a prognostic factor for survival in patients with head and neck squamous cell carcinoma.
    Sano D; Yabuki K; Takahashi H; Arai Y; Chiba Y; Tanabe T; Nishimura G; Oridate N
    Auris Nasus Larynx; 2018 Aug; 45(4):846-853. PubMed ID: 29203318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Positive lymph node ratio is an important prognostic factor of oral squamous cell carcinoma].
    Yang S; Wang D; Wang X; Mao C
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2016 Mar; 51(3):133-6. PubMed ID: 26980649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph node ratio is associated with adverse clinicopathological features and is a crucial nodal parameter for oral and oropharyngeal cancer.
    Feng Z; Xu QS; Wang C; Li JZ; Mao MH; Li H; Qin LZ; Han Z
    Sci Rep; 2017 Jul; 7(1):6708. PubMed ID: 28751709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Impact of regional positive lymph node ratio of gallbladder carcinoma on prognosis].
    Zhou YM; Mi HC; Jiang W; Jiang Y; Hua YF; Lu CJ; Wang CN; Lu CD
    Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1202-1207. PubMed ID: 36380669
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic value of lymph node involvement in oral squamous cell carcinoma.
    Voss JO; Freund L; Neumann F; Mrosk F; Rubarth K; Kreutzer K; Doll C; Heiland M; Koerdt S
    Clin Oral Investig; 2022 Nov; 26(11):6711-6720. PubMed ID: 35895143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node ratio as a valuable additional predictor of outcome in selected patients with oral cavity cancer.
    Künzel J; Mantsopoulos K; Psychogios G; Grundtner P; Koch M; Iro H
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Jun; 117(6):677-84. PubMed ID: 24842444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph node ratio as prognostic variable in oral squamous cell carcinomas: Systematic review and meta-analysis.
    Huang TH; Li KY; Choi WS
    Oral Oncol; 2019 Feb; 89():133-143. PubMed ID: 30732951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the prognostic value of lymph node yield, lymph node ratio, and number of lymph node metastases in patients with oral squamous cell carcinoma.
    Struckmeier AK; Buchbender M; Lutz R; Agaimy A; Kesting M
    Head Neck; 2024 May; 46(5):1083-1093. PubMed ID: 38501325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic relevance of lymph node ratio in patients with oral squamous cell carcinoma treated with neoadjuvant therapy regimen and radical surgery.
    Rempel V; Safi AF; Drebber U; Nickenig HJ; Neugebauer J; Zöller JE; Kreppel M
    J Craniomaxillofac Surg; 2018 Sep; 46(9):1659-1663. PubMed ID: 30196863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymph node ratio-dependent prognosis stratification and postoperative radiotherapy utilization in T1-2N1 oral cavity carcinoma.
    Wang J; Liu Y; Shayan G; Ma Y; Yi J
    Radiother Oncol; 2022 Jul; 172():83-90. PubMed ID: 35568286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.